Contrast Induced Nephropathy Market will be dominated by Pharming Group NV, 2018

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Contrast Induced Nephropathy - Pipeline Review, H1 2018”

Contrast Induced Nephropathy

Overview

Contrast-induced nephropathy (CIN) is defined as the impairment of renal function (measured as either a 25%increase in serum creatinine (SCr) from baseline or a 0.5 mg/dL (44 μmol/L) increase in absolute SCr value after 48-72 hrs contrast administration). Symptoms include feeling more tired, poor appetite, swelling in the feet and ankles, puffiness around the eyes, or dry and itchy skin. Risk factors include age, diabetes, decreased kidney function and congestive heart failure. Treatment includes electrolyte management.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3031094-contrast-induced-nephropathy-pipeline-review-h1-2018

 

Major Key Players:

Pharming Group NV

Contrast Induced Nephropathy Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Contrast Induced Nephropathy    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Contrast Induced Nephropathy   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Contrast Induced Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Preclinical stages are 1 and 4 respectively.

Contrast Induced Nephropathy pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Contrast Induced Nephropathy - Competitive Analysis

Key players are making innovative developments in Contrast Induced Nephropathy industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Contrast Induced Nephropathy.

The pipeline guide reviews pipeline therapeutics for Contrast Induced Nephropathy by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Contrast Induced Nephropathy therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Contrast Induced Nephropathy therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Contrast Induced Nephropathy.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3031094-contrast-induced-nephropathy-pipeline-review-h1-2018

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.